IP Library Granted Patent US 12,577,371
Granted Patent B2
US 12,577,371 · App. 17/257,496 · Granted Mar 17, 2026

Oxidatively curable coating composition

Inventors: Johannes Wietse De Boer (Leiden, NL); Ronald Hage (Leiden, NL); Karin Maaijen (Leiden, NL); Yfranka Petronella Areke Roelofsen (Leiden, NL)
Assignee: Milliken Industrials Limited
C08K5/0091C08G63/83C09D167/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,577,371
App. No.
17/257,496
Granted
Mar 17, 2026
Kind
B2
Abstract

The present invention relates to an oxidatively curable coating formulation comprising an oxidatively curable alkyd-based resin and unsymmetrically substituted 1,4,7-triazacyclononane-based chelant, which chelant may optionally be complexed with a suitable transition metal ion, particularly manganese. The formulations may be paints or other oxidatively curable coating compositions. The invention also provides methods for making such formulations and compositions resultant from the curing of such formulations.

Claims (23)

1 . A formulation comprising:

an oxidatively curable alkyd-based curable resin and a chelant of the formula (I):

wherein:

R B and R C are both methyl;

R A is different to R B and R B is the same as R C ;

R A is benzyl or C 4-12 alkyl; and

each of R 1 -R 12 is the same and is hydrogen or C 1-4 alkyl, and

a complex which comprises the chelant and a transition metal ion selected from ions of manganese, wherein a molar ratio between the transition metal ion and the chelant in the formulation is between about 0.3:1 to 3:1.

2 . The formulation of claim 1 , wherein each of R 1 -R 12 is the same and is hydrogen.

3 . The formulation of claim 1 , wherein the complex is not isolated from the reaction medium in which it is prepared.

4 . A method of preparing a formulation, the method comprising contacting a composition comprising an alkyd-based resin with a composition comprising a chelant of formula (I):

wherein:

R B and R C are both methyl;

R A is different to R B and R B is the same as R C ;

R A is benzyl or C 4-12 alkyl; and

each of R 1 -R 12 is the same and is hydrogen or C 1-4 alkyl, and

the method further comprising a step of contacting the composition comprising an alkyd-based resin with a source of manganese transition metal ion, wherein a molar ratio between the manganese transition metal ion and the chelant in the resultant formulation is between about 0.3:1 to 3:1.

5 . The method of claim 4 , wherein the formulation formed by the method of claim 4 comprises a well-defined complex formed of the chelant of formula (I) and the manganese transition metal ion.

6 . A kit comprising a first formulation comprising the alkyd-based curable resin and chelant of claim 1 and, separately, a composition comprising the transition metal ion of claim 1 .

7 . The formulation of claim 1 , wherein the chelant is present in the formulation at a concentration of between about 0.00005 and about 0.5 wt. % with respect to oxidatively curable alkyd-based curable resin.

8 . The formulation of claim 7 , wherein the chelant is present in the formulation at a concentration of between about 0.001 and about 0.1 wt. % with respect to oxidatively curable alkyd-based curable resin.

9 . The formulation of claim 1 , further comprising an antiskinning agent.

10 . The method of claim 4 , wherein the source of transition metal ion is an optionally hydrated salt selected from the group consisting of MnSO 4 , MnCl 2 , MnBr 2 , Mn(NO 3 ) 2 , Mn(CH 3 COO) 2 , Mn(CH 3 COO) 2 , Mn(acetylacetonate) 2 , Mn(acetylacetonate) 3 , Mn(octanoate) 2 , Mn(2-ethylhexanoate) 2 , Mn(naphthenate) 2 , and Mn(neodecanoate) 2 .

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2023
From: DE BOER, JOHANNES WIETSE; HAGE, RONALD; MAAIJEN, KARIN; ROELOFSEN, YFRANKA PETRONELLA AREKE
To: CHEMSENTI B.V.
Reel/Frame 063576/0771 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2023
From: CHEMSENTI B.V.
To: CATEXEL LIMITED
Reel/Frame 063576/0832 →
CHANGE OF NAME Recorded May 9, 2023
From: CATEXEL LIMITED
To: BORCHERS CATALYST (UK) LIMITED
Reel/Frame 063577/0301 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2023
From: BORCHERS CATALYST (UK) LIMITED
To: BORCHERS ADDITIVES (UK) LIMITED
Reel/Frame 063540/0724 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2023
From: BORCHERS ADDITIVES (UK) LIMITED
To: MILLIKEN INDUSTRIALS LIMITED
Reel/Frame 063540/0809 →
Priority Claims (1)
EP 18181879 · Jul 5, 2018 · regional
Continuity (1)
Related Publication 20210221975A1 · Jul 22, 2021
References Cited (16)
US 2063838A · Bruson et al. · 1936 [cited by examiner]
US 20150337165A1 · De Boer · 2015 [cited by applicant]
US 20160304747A1 · Ang · 2016 [cited by applicant]
CN 105073920 · 2015 [cited by applicant]
CN 106062096 · 2016 [cited by applicant]
CN 107109110 · 2017 [cited by applicant]
EP 2954015A1 · 2015 [cited by applicant]
EP 3037464A1 · 2016 [cited by applicant]
EP 3272823A1 · 2018 [cited by applicant]
JP 4200466B2 · 2008 [cited by applicant]
KR 20160118291 · 2016 [cited by applicant]
WO 2008114864A1 · 2008 [cited by applicant]
WO 2014122433 · 2014 [cited by applicant]
WO 2015082553A1 · 2015 [cited by applicant]
Koek (Synthesis and properties of hydrophobic [MnIV2(μ-O)3(L)2]2+ complexes, derived from alkyl substituted 1,4,7-triazacylononane ligands, Inorganica Chimica Acta, 295, 1999, pp. 189-199). [cited by examiner]
International Search Report and Written Opinion issued in PCT/GB2019/051900 on Aug. 29, 2019 (11 pages). [cited by applicant]